undamentalytics Newsletter
Sign in

Avient Corp (AVNT) stock

Add to watchlist

Add holding +

NYSE: AVNT NYSE Specialty Chemicals Next results ~November 4, 2026

C+ Fundamentals grade

Avient Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$13

Cash-flow model

Base case. Range ~$5.3–$22 across our lower- and higher-growth cases (-3%–7% a year).

Price vs value

Overvalued

The price is above our entire value range; our base value is 71% below it.

Price used: $43.45, November 2, 2026

Avient Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Avient files

Where Avient stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.33bn, up 2.4% on a year earlier, faster than the 1.3% growth a quarter earlier. Free-cash-flow margin rose to 5.7% from 4.6% a year earlier. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 5 financial-health checks. Our cash-flow model value is $12.64 a share, against a share price of $41.33. At that price, our model says the market is pricing in about 14.5% a year of cash-flow growth for five years, faster than the 0.1% a year revenue growth it has delivered.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Avient Corp's trailing-twelve-month revenue grew 2.4% year on year, with a free-cash-flow margin of 5.7%. Where it stands out: stock pay as % of revenue of 0.3% ranks 2 of 36 specialty chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$13 per share in the base case (~$5.3–$22 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 27.4% while net income grew 43.0%: a 16pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Priced above our value. The share price of $43.45 is 71% above our value per share of $13.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$0.96 against an average estimate of $0.89: beat by 7.7%
Revenue
$917m, up 5.8% on a year earlier
Share reaction
-4.9% in the first session after the results on October 9, 2026, against +0.5% for the S&P 500
Next report
November 4, 2026; average EPS estimate $0.80

Avient's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.4%
  • 1 week+5.3%
  • 1 month+5.5%
  • This year+42.2%
  • 1 year+39.7%
  • 5 years-11.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.3B
Operating margin
9.5%
Net margin
5.1%
EPS (TTM, diluted)
$1.85

Growth

Revenue growth
+2.4%
Change in growth rate
+1.0 pts
Share count change
+0.2%

Cash

Free cash flow (TTM)
$191M
FCF margin
5.7%
Stock pay % of revenue
0.3%

Earnings

Last results
October 9, 2026
Next results (est.)
January 6, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Avient Corp valuation models and calculator

What the price is pricing in

The share price implies about 15.1% a year of cash-flow growth for five years.That is faster than the 0.1% a year revenue growth Avient has delivered.

  • Priced in15.1%
  • Last 12 months2.4%
  • 3 years a year0.5%
  • 5 years a year0.1%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($43.23, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$13
Price used
$43.23close November 3, 2026
Implied change
▼ 71%
Uncertainty
Very high

How we got here: a discounted-cash-flow model of Avient Corp's free cash flow after stock-based pay with after-tax interest added back ($159M, FY2026 Q2 TTM), growing 3.5% and 2.3% in the next two years (forecasts, guidance and its record), then back to 2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$5.3–~$22 ; that spread sets a 45% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Avient Corp's free cash flow after stock-based pay ( $159M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Avient Corp as an operating company, with every model that fits that kind of business. Cost of equity 9.6%: the 10-year Treasury yield (4.9%) plus a beta of 1.03 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$13 ~$5.3–$22 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$51 ~$41–$61 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$33 ~$24–$46 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$35 ~$31–$42 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$29 ~$13–$51 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Avient Corp with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −48%
  • Revenue growth 5 points higher ▲ +63%
  • Free-cash-flow margin 1 point lower ▼ −33%
  • Last year's free-cash-flow margin change, if it persists ▲ +60%
  • Discount rate 1 point higher ▼ −27%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $8$17$29$45$65$91
8.5% $2$9$17$29$43$62
10% —$4$10$19$30$44

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$25.37$34.98$23.43$30.91$34.91$49.34$30.48$38.52$38.76$30.56$43.45
Market value$2.1bn$2.9bn$1.9bn$2.4bn$3.2bn$4.5bn$2.8bn$3.5bn$3.6bn$2.8bn$4.0bn
+ Net debt (− = net cash)$1.0bn$1.1bn$1.2bn$378m$1.2bn$1.3bn$1.6bn$1.6bn$1.6bn$1.4bn$1.5bn
Enterprise value$3.2bn$4.0bn$3.1bn$2.8bn$4.4bn$5.8bn$4.4bn$5.1bn$5.1bn$4.2bn$5.5bn
Multiples
Price / sales 0.7x1.1x0.7x0.8x1.4x1.4x0.8x1.1x1.1x0.9x1.2x
Price / earnings 13.0x—11.8x4.1x24.0x19.7x4.0x46.7x21.0x34.2x23.5x
Price / free cash flow 15.0x23.4x10.6x11.0x20.0x34.1x9.6x43.0x26.4x14.4x21.0x
EV / EBITDA 8.7x14.6x11.5x11.4x19.7x13.7x10.8x13.2x10.1x10.9x10.8x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

51 /100

Moderate moat

How hard Avient's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 6 / 20

    Cash operating profit has been a median 5.6% of total assets over 10 years.

  • Pricing power 7 / 20

    Gross margin has been a median 25.2%, moving by 4.5 percentage points (standard deviation) across 10 years.

  • Durability 9 / 20

    Operating margin has been a median 7.0%; its worst year was 4.0%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 10 of 10 years, at a median 5.2% of revenue.

  • Discipline 17 / 20

    The diluted share count fell 0.1% over five years; stock-based pay has been a median 0.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, before the open. Analysts expect revenue of $859m and EPS of $0.80 (range $0.80 to $0.81) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $3.20 +14% $3.4bn +5%
Next $3.52 +10% $3.5bn +3%

Next year's EPS estimate has moved +4.0% in 90 days, across 9 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +4.2% on 90 days ago. In the last 30 days, 7 analysts raised Avient Corp's forecast and 0 cut it.

Consensus EPS forecast Avient Corp, last 90 days
$3.00 $3.20 $3.40 $3.60 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $3.07 Current fiscal year, 60 days ago: $3.20 Current fiscal year, 30 days ago: $3.20 Current fiscal year, 7 days ago: $3.20 Current fiscal year, Now: $3.20 $3.20 Next fiscal year, 90 days ago: $3.38 Next fiscal year, 60 days ago: $3.50 Next fiscal year, 30 days ago: $3.50 Next fiscal year, 7 days ago: $3.50 Next fiscal year, Now: $3.52 $3.52

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $3.07$3.38
60 days ago $3.20$3.50
30 days ago $3.20$3.50
7 days ago $3.20$3.50
Now $3.20$3.52

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.89 $0.96 +7.7%
Mar 2026 $0.81 $0.83 +2.8%
Dec 2025 $0.55 $0.56 +2.3%
Sept 2025 $0.69 $0.70 +1.5%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 9, 2026

No numeric guidance in Avient Corp's latest earnings release (filed October 9, 2026). Some companies give their outlook only on the earnings call.

How our valuation uses these forecasts

Our cash-flow model grows Avient Corp's revenue by +3.5% next year and +2.3% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+4.3%, weight 67%) and the company's own record (+2.0%, weight 33%) . How the weights are set.

Analyst recommendations

8 analysts, Nov 2026
Buy563%
Hold338%
Sell00%

Monthly trend

  1. Nov 2026538
  2. Oct 2026527
  3. Sep 2026527

Counts of recommendations published by analysts covering Avient Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.4%
of tradable shares
Days to cover
5.09
at average volume
Short interest, 1 month
+7%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.9%
of shares
Employees
9,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +39.7%

$31.09 on October 31, 2025 to $43.45

ThenNowEffect
Revenue (last 12 months) $3.3bn $3.3bn +2.4%
Net margin 3.7% 5.1% +39.7%
P/E multiple 24.0x 23.5x −2.0%
Share count 92m 92m −0.2%

Biggest factor: net margin.

Last 3 years +39.0%

$31.26 on November 3, 2023 to $43.45

ThenNowEffect
Revenue (last 12 months) $3.3bn $3.3bn +1.5%
Net margin 17.5% 5.1% −70.9%
P/E multiple 5.0x 23.5x +370.9%
Share count 92m 92m 0.0%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
AVNT+41%−38%+26%+1%−21%+42%
Industry peers (median)+17%−25%−9%+7%−13%+5%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
AVNT67%50%42%58%33%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
AVNT−16%−50%−28%−24%−37%−26%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 77% from November 6, 2017 to March 18, 2020. Getting back needed a 333% gain, reached on January 6, 2021, 294 days after the low.

Price behaviour

52-week range
$26.64 – $46.03
From 52-week high
−5.6%
vs 50-day average
+4.9%
vs 200-day average
+14.0%
Volatility (1 year)
36%
Beta vs S&P 500
1.07

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
8 up, 4 down
typical move ±6.3%
After a week
9 up, 3 down
typical move ±7.9%
After a month
7 up, 4 down
typical move ±9.2%
Results releasedNext dayS&P 500 next day5 days21 days
October 9, 2026 −4.9% +0.5% −4.9% —
August 6, 2026 +20.5% +0.5% +21.6% +14.5%
May 7, 2026 −2.5% +0.5% −8.1% −8.9%
February 12, 2026 +4.6% −1.5% +4.2% −16.0%
November 5, 2025 −3.6% −0.7% −5.8% −1.9%
August 1, 2025 +7.7% −0.1% +4.1% +16.0%
May 6, 2025 +6.2% −0.4% +14.1% +6.9%
February 13, 2025 +3.0% +1.1% +4.0% −2.6%
October 31, 2024 −4.9% −1.5% +6.0% +6.3%
August 6, 2024 +6.3% +0.2% +10.8% +13.2%
May 7, 2024 +1.5% +0.1% +2.0% +1.4%
February 14, 2024 +9.5% +1.6% +8.8% +13.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Avient Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read October 29, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: rated Sell.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Avient Corp in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Avient Corp
$3.1B $3.2B $3.3B $3.4B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $3.2B Revenue (TTM), FY23 Q4: $3.1B Revenue (TTM), FY24 Q1: $3.1B Revenue (TTM), FY24 Q2: $3.2B Revenue (TTM), FY24 Q3: $3.2B Revenue (TTM), FY24 Q4: $3.2B Revenue (TTM), FY25 Q1: $3.2B Revenue (TTM), FY25 Q2: $3.3B Revenue (TTM), FY25 Q3: $3.2B Revenue (TTM), FY25 Q4: $3.3B Revenue (TTM), FY26 Q1: $3.3B Revenue (TTM), FY26 Q2: $3.3B $3.3B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $3.2B
FY23 Q4 $3.1B
FY24 Q1 $3.1B
FY24 Q2 $3.2B
FY24 Q3 $3.2B
FY24 Q4 $3.2B
FY25 Q1 $3.2B
FY25 Q2 $3.3B
FY25 Q3 $3.2B
FY25 Q4 $3.3B
FY26 Q1 $3.3B
FY26 Q2 $3.3B
Revenue growth, TTM YoY Avient Corp
-10% -5% 0% 5% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -5.8% Revenue growth, TTM YoY, FY23 Q4: -7.5% Revenue growth, TTM YoY, FY24 Q1: -6.7% Revenue growth, TTM YoY, FY24 Q2: -4.0% Revenue growth, TTM YoY, FY24 Q3: -0.0% Revenue growth, TTM YoY, FY24 Q4: 3.1% Revenue growth, TTM YoY, FY25 Q1: 3.6% Revenue growth, TTM YoY, FY25 Q2: 3.3% Revenue growth, TTM YoY, FY25 Q3: 1.0% Revenue growth, TTM YoY, FY25 Q4: 0.6% Revenue growth, TTM YoY, FY26 Q1: 1.3% Revenue growth, TTM YoY, FY26 Q2: 2.4% 2.4%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -5.8%
FY23 Q4 -7.5%
FY24 Q1 -6.7%
FY24 Q2 -4.0%
FY24 Q3 -0.0%
FY24 Q4 3.1%
FY25 Q1 3.6%
FY25 Q2 3.3%
FY25 Q3 1.0%
FY25 Q4 0.6%
FY26 Q1 1.3%
FY26 Q2 2.4%
Operating margin (TTM) Avient Corp
4% 6% 8% 10% 12% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 4.8% Operating margin (TTM), FY23 Q4: 6.3% Operating margin (TTM), FY24 Q1: 7.5% Operating margin (TTM), FY24 Q2: 7.7% Operating margin (TTM), FY24 Q3: 8.9% Operating margin (TTM), FY24 Q4: 10.2% Operating margin (TTM), FY25 Q1: 7.3% Operating margin (TTM), FY25 Q2: 8.0% Operating margin (TTM), FY25 Q3: 7.7% Operating margin (TTM), FY25 Q4: 6.2% Operating margin (TTM), FY26 Q1: 9.1% Operating margin (TTM), FY26 Q2: 9.5% 9.5%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 4.8%
FY23 Q4 6.3%
FY24 Q1 7.5%
FY24 Q2 7.7%
FY24 Q3 8.9%
FY24 Q4 10.2%
FY25 Q1 7.3%
FY25 Q2 8.0%
FY25 Q3 7.7%
FY25 Q4 6.2%
FY26 Q1 9.1%
FY26 Q2 9.5%
FCF margin (TTM) Avient Corp
0% 2% 4% 6% 8% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 3.0% FCF margin (TTM), FY23 Q4: 2.6% FCF margin (TTM), FY24 Q1: 1.8% FCF margin (TTM), FY24 Q2: 5.1% FCF margin (TTM), FY24 Q3: 5.1% FCF margin (TTM), FY24 Q4: 4.2% FCF margin (TTM), FY25 Q1: 4.3% FCF margin (TTM), FY25 Q2: 4.6% FCF margin (TTM), FY25 Q3: 4.7% FCF margin (TTM), FY25 Q4: 6.0% FCF margin (TTM), FY26 Q1: 6.3% FCF margin (TTM), FY26 Q2: 5.7% 5.7%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 3.0%
FY23 Q4 2.6%
FY24 Q1 1.8%
FY24 Q2 5.1%
FY24 Q3 5.1%
FY24 Q4 4.2%
FY25 Q1 4.3%
FY25 Q2 4.6%
FY25 Q3 4.7%
FY25 Q4 6.0%
FY26 Q1 6.3%
FY26 Q2 5.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 2,061 2,622 2,709 2,861 3,771 3,836 2,939 2,590 2,881 2,863 2,215 3,316 3,397 3,143 3,240 3,260 3,332
Gross profit 324 429 429 531 662 708 676 596 625 657 660 944 883 893 1,057 1,016 1,055
EBITDA 202 230 261 207 341 279 368 271 267 244 223 424 406 386 509 389 505
Operating income 137 175 203 138 232 155 268 173 179 157 112 280 243 197 329 204 315
Net income 107 163 173 72 244 79 165 −58 160 589 132 231 703 76 170 82 170
Diluted EPS $1.14 $1.69 $1.84 $0.80 $2.53 $0.85 $1.95 −$0.70 $1.99 $7.58 $1.45 $2.51 $7.63 $0.83 $1.84 $0.89 $1.85
Growth (year on year)
Revenue — +27.2% +3.3% +5.6% +31.8% +1.7% −23.4% −11.9% +11.2% −0.6% −22.6% +49.7% +2.5% −7.5% +3.1% +0.6% +2.4%
EBITDA — +13.8% +13.4% −20.4% +64.6% −18.3% +32.0% −26.5% −1.3% −8.5% −8.6% +89.7% −4.1% −5.1% +32.0% −23.5% +14.3%
Operating income — +27.4% +16.3% −32.3% +68.4% −33.0% +72.6% −35.3% +3.2% −12.2% −28.8% +150.6% −13.0% −19.1% +67.3% −38.2% +21.3%
Net income — +52.4% +6.2% −58.3% +239.1% −67.5% +108.6% −134.9% — +268.3% −77.6% +75.4% +204.6% −89.2% +123.9% −51.7% +43.0%
Diluted EPS — +48.2% +8.9% −56.5% +216.3% −66.4% +129.4% −135.9% — +280.9% −80.9% +73.1% +204.0% −89.1% +121.7% −51.6% +42.6%
Margins
Gross margin 15.7% 16.4% 15.8% 18.6% 17.6% 18.5% 23.0% 23.0% 21.7% 23.0% 29.8% 28.5% 26.0% 28.4% 32.6% 31.2% 31.7%
EBITDA margin 9.8% 8.8% 9.6% 7.2% 9.1% 7.3% 12.5% 10.4% 9.3% 8.5% 10.1% 12.8% 12.0% 12.3% 15.7% 11.9% 15.2%
Operating margin 6.7% 6.7% 7.5% 4.8% 6.1% 4.0% 9.1% 6.7% 6.2% 5.5% 5.0% 8.4% 7.2% 6.3% 10.2% 6.2% 9.5%
Net margin 5.2% 6.2% 6.4% 2.5% 6.5% 2.1% 5.6% −2.2% 5.5% 20.6% 5.9% 7.0% 20.7% 2.4% 5.2% 2.5% 5.1%
Free-cash-flow margin 9.6% 3.9% 0.7% 1.7% 0.9% 3.0% 4.9% 4.7% 6.2% 7.7% 7.1% 4.0% 8.6% 2.6% 4.2% 6.0% 5.7%
Cash flow
Cash from operations 230 141 73 107 109 208 228 202 254 301 222 234 398 202 257 302 299
Capital spending 32 40 54 57 76 93 84 80 76 82 64 101 106 119 122 107 108
Free cash flow 198 101 18 50 33 116 143 123 178 219 158 133 293 82 135 195 191
Stock-based pay 3 4 5 10 17 14 8 10 11 12 11 11 13 13 15 9 9
Free cash flow after stock pay 195 97 13 39 16 101 135 113 167 208 147 122 280 69 120 186 182
Balance sheet
Cash 223 378 192 210 365 239 227 244 171 865 650 601 641 546 545 511 426
Total debt 0 453 707 709 989 1,024 1,274 1,324 1,372 1,243 1,892 1,873 2,216 2,111 2,099 1,949 1,899
Net debt (negative = net cash) −223 75 515 499 624 785 1,047 1,080 1,201 378 1,242 1,272 1,575 1,565 1,555 1,438 1,473
Diluted shares 93m 96m 94m 90m 97m 94m 85m 82m 80m 78m 91m 92m 92m 92m 92m 92m 92m
Returned to shareholders
Dividends — 0 −11 17 22 30 40 44 56 60 71 78 87 90 94 99 100
Buybacks — 0 74 16 132 233 86 71 123 27 22 4 36 0 0 — —
Total returned — 0 63 33 153 263 126 115 179 87 94 82 123 90 94 99 100

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 5 checks passed · June 30, 2026
What it owns · $6.0bn
Short-term assets $1.5bnLonger-term assets $4.5bn
What it owes, and who funded it · $3.2bn
Short-term liabilities $807mShareholders' equity $2.4bn
  • Short-term assets cover short-term liabilities $1.5bn of assets due within a year against $807m of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $426m of cash against $1.9bn of debt.
  • Debt below 40% of shareholders' equity Debt is 77% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 104% to 77% over five years.
  • A year's operating cash flow covers at least 20% of debt $299m of operating cash flow against $1.9bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Avient Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$99.8M
Diluted share count
+0.2%
year over year
Total shareholder yield
2.5%
dividends 2.5% + buybacks 0.0% of market value
Dividend payout ratio
59%
of net income paid out
Sales & admin spending
22.2%
of revenue
Days sales outstanding
61 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in specialty chemicals
Last 12 months unless stated AVNT ESI FUL CBT NEU SCL Median
Revenue, last 12 months $3.3bn $3.5bn $3.6bn $3.6bn $2.8bn $2.4bn $906m
Revenue growth, last 12 months 2.4% 39.6% 1.5% −4.7% 0.9% 7.6% 5.4%
Revenue growth, 3-year average 0.5% 14.4% −0.1% −3.8% 0.4% −1.9% 0.9%
Revenue growth, latest quarter 5.8% 51.7% 5.2% 6.4% 3.8% 15.0% 8.3%
Gross margin 31.7% 36.6% 32.3% 22.7% 31.7% 11.8% 28.8%
Operating margin 9.5% 11.7% 9.5% 13.6% 20.2% 0.8% 4.3%
Operating margin, 3-year average 8.4% 13.0% 9.9% 15.2% 20.3% 2.3% 5.5%
Net margin 5.1% 5.9% 5.6% 5.2% 16.5% −0.1% 0.8%
Cash from operations / revenue 9.0% 8.1% 8.1% 13.7% 18.1% 6.4% 6.9%
Free-cash-flow margin 5.7% 5.2% 2.8% 7.7% 13.8% 1.5% 4.3%
Free-cash-flow margin, 3-year average 5.1% 9.1% 4.5% 9.0% 16.4% 1.1% 5.1%
Stock pay / revenue 0.3% 2.2% 0.7% 0.5% 0.1% 0.3% 1.0%
Change in share count 0.2% 0.4% −0.9% −3.7% −1.9% −0.0% 0.1%

Median of all 42 companies we cover in specialty chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

42 specialty chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 2.4% 6.0% 26 of 42
Change in growth rate Growth +1.0pp +1.3pp 24 of 42
Gross margin Profitability 31.7% 31.5% 18 of 40
Operating margin Profitability 9.5% 3.8% 11 of 39
Net margin Profitability 5.1% 1.7% 16 of 42
Free-cash-flow margin Cash generation 5.7% 4.8% 16 of 42
Stock pay as % of revenue Cash generation 0.3% 1.0% 2 of 36
Long-term debt as % of assets Balance sheet 31.2% 26.8% 24 of 36
Change in share count Balance sheet 0.2% 0.0% 20 of 37
Days sales outstanding Balance sheet 61 days 59 days 17 of 30

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States and Canada $1.3B 40.2% ▼ 2.0%
EMEA $1.2B 36.1% ▲ 1.8%
Asia $593M 18.2% ▲ 4.1%
Latin America $182M 5.6% ▲ 1.3%

From Avient Corp's 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$3.6B
Institutions reporting
344
Shares held vs prior quarter
▲ 4.2%
Positions opened / closed
40 / 37

Top buyers and sellers, Q2 2026: 181 institutions bought and 144 sold ; the biggest buyer was Ophir Asset Management Pty Ltd (+1.3M shares) and the biggest seller Franklin Resources Inc (−3.0M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $437M 11.8M 12.2% ▲ 6.6%
Vanguard Portfolio Management LLC $210M 5.7M 5.9% ▲ 3.4%
Dimensional Fund Advisors LP $194M 5.3M 5.4% ▲ 5.8%
Vanguard Capital Management LLC $152M 4.1M 4.3% ▲ 0.2%
State Street Corp $143M 3.8M 4.0% ▲ 8.0%
Alliancebernstein L.P. $127M 3.5M 3.5% ▲ 30.7%
Wellington Management Group LLP $111M 3.0M 3.1% ▲ 2.7%
Geode Capital Management, LLC $92.6M 2.5M 2.6% ▲ 6.2%
Channing Capital Management, LLC $88.1M 2.4M 2.5% ▲ 16.9%
Allspring Global Investments Holdings, LLC $83.7M 2.3M 2.3% ▼ 23.7%
Invesco Ltd. $73.1M 2.0M 2.0% ▲ 7.9%
Jennison Associates LLC $68.9M 1.9M 1.9% ▲ 32.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Avient Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

In the last 12 months, 1 member of Congress disclosed 1 purchase and 0 sales of Avient Corp shares.

  • Gilbert Ray Cisneros, Jr.(D-CA 31):Purchase, $1,001 - $15,000, traded March 3, 2026, filed April 7, 2026
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Purchase, $1,001 - $15,000, traded September 2, 2025, filed September 12, 2025
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded June 17, 2025, filed August 13, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 6, 2027 estimated from the company's past filing pattern, not announced

  • October 9, 2026
  • August 6, 2026
  • May 7, 2026
  • February 12, 2026
  • November 5, 2025
  • August 1, 2025

Recent SEC filings

Data status

When each part of this page on Avient Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Avient Corp in brief

What does Avient Corp do?
Avient Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in December.
What is Avient Corp's stock ticker?
Avient Corp trades under the ticker AVNT on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Avient Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Avient Corp reported revenue of $3.3B, 2.4% higher than a year earlier, according to its SEC filings.
What is Avient Corp's free cash flow?
Avient Corp's free-cash-flow margin is 5.7% of revenue over the trailing twelve months, ranking 16 of the 42 specialty chemicals companies we cover.
What is Avient Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Avient Corp's free cash flow after stock-based pay gives ~$13 per share in the base case, and ~$5.3–$22 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Avient Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and Dimensional Fund Advisors LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Avient Corp's market cap?
On November 2, 2026, Avient Corp's market capitalisation was about $4B, with a price-to-earnings ratio of 23.5 and net debt of $1.5B. Market figures come from third-party market data and may be delayed.
Does Avient Corp pay a dividend?
Yes: Avient Corp paid $99.8M in dividends over the trailing twelve months, a dividend yield of 2.49% and a payout ratio of 58.7%.
How much debt does Avient Corp have?
Avient Corp's debt-to-equity ratio is 77.0%, from its latest balance sheet (104.3% five years earlier). The financial health section below sets out its other solvency checks.
Who are Avient Corp's competitors?
In our Specialty Chemicals peer group, the companies closest to Avient Corp are Element Solutions Inc, Fuller H B Co, Cabot Corp, Newmarket Corp and Stepan Co. The side-by-side comparison below sets their revenue, margins and growth against Avient Corp's.
When is Avient Corp's next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Avient Corp announces its own schedule.